Incyte Corp.-0.329 %

Daily Stock Price

CEO

Hervé Hoppenot


Company Symbol

INCY


Exchange

NASDAQ


Industry

Biotechnology


Information

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.


*latest update 2020-05-13

Monthly Stock Price

Financial Ratios

Institutional Holders

HolderSharesDate Reported% OutValue
Baker Brothers Advisors, LLC31,978,785Mar 30, 202014.71%2,341,806,425
Vanguard Group, Inc. (The)20,583,954Mar 30, 20209.47%1,507,362,951
Price (T.Rowe) Associates Inc18,640,426Mar 30, 20208.58%1,365,038,395
Blackrock Inc.15,312,371Mar 30, 20207.04%1,121,324,928
Wellington Management Company, LLP13,307,643Mar 30, 20206.12%974,518,696
Capital International Investors9,468,175Mar 30, 20204.36%693,354,455
State Street Corporation8,369,821Mar 30, 20203.85%612,921,991
Renaissance Technologies, LLC4,602,260Mar 30, 20202.12%337,023,499
Dodge & Cox Inc3,992,600Mar 30, 20201.84%292,378,098
Ubs Asset Management Americas Inc3,643,461Mar 30, 20201.68%266,810,649

Search a Stock from the NASDAQ 100

We are redirecting you to